On November 2, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) announced they have now published the list of drug products currently undergoing review under their new continuous evaluation process on their website.

Citizens, health professionals, patients and their caregivers, as well as their associations or groups may provide comments on any of the drug products by the specified deadline. To do so, INESSS invites you to fill out one of the two questionnaires on their website or to send your comments by e-mail to plan.commentaires.inscription@inesss.qc.ca.

For more information, please consult the following link or the INESSS website.